Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway

Overview of attention for article published in Drug Design, Development and Therapy, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 11,300 followers.

RT @Osteoporosis_NL: Orexin-A reverse bone mass loss induced by chronic intermittent hypoxia through OX1R-Nrf2/HIF-1alpha pathway. H Gu et…

23 Jul 2022

Reply Repost Favourite

Orexin-A reverse bone mass loss induced by chronic intermittent hypoxia through OX1R-Nrf2/HIF-1alpha pathway. H Gu et al. Drug Des Devel Ther 2022 Jul 5 https://t.co/hex9826eWX …first time …new therapeutic method for obstructive sleep apnea OSA with bone l

23 Jul 2022

Reply Repost Favourite

Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway https://t.co/goZ1I8oEyF

12 Jul 2022

Reply Repost Favourite

Dove Medical Press

Article Metrics

Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway

About this Attention Score

Mentioned by

Citations

Readers on